Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Abroad (travel likely)RecruitingPHASE3

Conditions

Neuromyelitis Optica Spectrum Disorders (NMOSD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University General Hospital, Department of Neurology, Tianjin, China
Contact: Study coordinator (Chao Zhang) · chaozhang@tmu.edu.cn · +8602260814587

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica Spectrum Disorder · NMOSD

Abroad (travel likely)RecruitingPHASE3

Denver, United States · Ciudad Autonoma Buenos Aires, Argentina

A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

Neuromyelitis Optica Spectrum Disorders

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China · Beijing, China

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Neuromyelitis Optica Spectrum Disorder · NMOSD · AQP4+ NMOSD

Abroad (travel likely)Recruiting

Washington D.C., United States · Boston, United States

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Neuromyelitis Optica Spectrum Disorders (NMOSD) · Multiple Sclerosis · Autoimmune Encephalitis

Abroad (travel likely)Recruiting

Guangzhou, China